TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/08/19	21 : 00	PR Newswire (Canada)	Teva Canada announces product availability of AJOVY™	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	16 : 02	Dow Jones News	States Press Opioid Litigation -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	16 : 02	Dow Jones News	Teva's U.S. Unit Accused of Using Donations to Aid Drug Business -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	03 : 48	Dow Jones News	Prosecutors Sue Teva's U.S. Business Over Charitable Donations -- 2nd Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	03 : 05	Dow Jones News	Prosecutors Sue Teva's U.S. Business Over Charitable Donations -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	03 : 03	Dow Jones News	Prosecutors Sue Teva's U.S. Business Over Charitable Donations	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/19	02 : 39	Dow Jones News	Justice Department Alleges Teva Pharmaceutical's U.S. Business Violated Anti-Kickback Law	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/18	18 : 59	Dow Jones News	States Seek $26.4 Billion From Drug Companies in Opioid Litigation	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/17	22 : 13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/15	00 : 18	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 15	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/14	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/07	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 49	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 44	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 42	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/06	05 : 06	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/05	20 : 10	Business Wire	Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/05	20 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/08/05	20 : 00	Business Wire	Teva Reports Second Quarter 2020 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/07/30	15 : 00	Business Wire	Teva Announces New Strategic Focus in the Japanese Market	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/07/29	21 : 00	Business Wire	Teva Announces New Drug Application Filing in Japan for AJOVY® (fremanezumab) Injection	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/07/13	21 : 30	GlobeNewswire Inc.	Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd